Company / Net Debt per Share
ENDONOVO THERAPEUTICS, INC. Net Debt per Share History
FY2014-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$0.10
FY2022
5-year range
$0.02 / $15.90
FY2018-FY2022
Trend
-67.1%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Debt per Share has declined for 3 consecutive years, from $15.90 in FY2019 to $0.10 in FY2022.
Based on SEC 10-K filings.
0.10 in FY2022 with a 3-year CAGR of -81.8%.
Improved from $5.74 to $0.10 over the past 2 years.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -81.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- ENDONOVO THERAPEUTICS, INC.'s net debt per share has declined for 3 consecutive years.
- In FY2022, net debt per share decreased 67.1% year-over-year.
- Peak net debt per share was recorded in FY2019.
- Lowest net debt per share in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -76.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0.10 | -67.1% |
| FY2021 | $0.29 | -94.9% |
| FY2020 | $5.74 | -63.9% |
| FY2019 | $15.90 | +64702.3% |
| FY2018 | $0.02 | -18.0% |
| FY2016 | $0.03 | +19109.3% |
| FY2015 | -$0.00 | -100.0% |
| FY2014 | $1.89 | - |
| FY2011 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 29, 2026